<i>In vivo</i> programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models.
- DOI
- 10.3389/fimmu.2024.1501365
- Published
- 2024-12-13
- Container
- Front Immunol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2024.1501365,
title = {\<i\>In vivo\</i\> programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models.},
author = {Argueta S and Wang Y and Zhao H and Diwanji N and Gorgievski M and Cochran E and Grudzien-Nogalska E and D'Alessandro J and McCreedy B and Prod'homme T and Hofmeister R and Ding J and Getts D.},
year = {2024},
journal = {Front Immunol},
doi = {10.3389/fimmu.2024.1501365},
url = {https://doi.org/10.3389/fimmu.2024.1501365}
}RIS
TY - JOUR TI - <i>In vivo</i> programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models. AU - Argueta S AU - Wang Y AU - Zhao H AU - Diwanji N AU - Gorgievski M AU - Cochran E AU - Grudzien-Nogalska E AU - D'Alessandro J AU - McCreedy B AU - Prod'homme T AU - Hofmeister R AU - Ding J AU - Getts D. PY - 2024 JO - Front Immunol DO - 10.3389/fimmu.2024.1501365 UR - https://doi.org/10.3389/fimmu.2024.1501365 ER -
APA
S, A., Y, W., H, Z., N, D., M, G., E, C., E, G., J, D., B, M., T, P., R, H., J, D., & D., G. (2024). <i>In vivo</i> programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models.. Front Immunol. https://doi.org/10.3389/fimmu.2024.1501365
Source records
- europe-pmc · retrieved 2026-09-26T22:42:35.159Z